What's next for Novo Nordisk's anti-obesity drug CagriSema?

A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…

Pfizer executives discuss anti-obesity drug Metsera

Albert Bourla, chairman and CEO of Pfizer, speaks at the Wall Street Journal's Future of Everything festival in New York…

Novo Nordisk and Pfizer executives weigh in

US President Donald Trump arrives to make an announcement in the Roosevelt Room of the White House in Washington, DC,…